Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom

Sponsors

Lead Sponsor: HaEmek Medical Center, Israel

Source HaEmek Medical Center, Israel
Brief Summary

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

Detailed Description

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.

The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.

Overall Status Completed
Start Date May 2008
Completion Date November 2008
Study Type Observational
Enrollment 60
Condition
Intervention

Intervention Type: Other

Intervention Name: Observational

Description: Summary of clinical and laboratory data

Eligibility

Sampling Method: Probability Sample

Criteria:

Inclusion Criteria: All patients admitted with fever as the only presenting symptom.

Exclusion Criteria: Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.

Gender: All

Minimum Age: N/A

Maximum Age: N/A

Healthy Volunteers: No

Overall Official
Location
Facility: Pediatric Hematology Unit - Ha'Emek Medical Center
Location Countries

Israel

Verification Date

August 2011

Responsible Party

Type: Principal Investigator

Investigator Affiliation: HaEmek Medical Center, Israel

Investigator Full Name: Dr Koren Ariel

Investigator Title: Head of Pediatric Hematology Unit and Pediatric Dpt B

Keywords
Has Expanded Access No
Condition Browse
Arm Group

Label: 1

Description: Sickle cell anemia

Label: 2

Description: Sickle cell thalassemia

Study Design Info

Time Perspective: Retrospective

Source: ClinicalTrials.gov